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Repunctuated Feminism: Marketing Menstrual 
Suppression Through the Rhetoric of Choice
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Abstract
This essay examines the rhetoric of choice as it is used by direct-to-consumer 
campaigns to persuade women to limit menstruation through the consump-
tion of oral contraceptives. Using the tools of feminist rhetorical criticism, I 
trace how choice is rhetorically constructed to suggest that menstrual suppres-
sion is a path to individual empowerment while co-opting second and post-
second-wave rhetorics. Finally, I explore the meaning of these constructions of 
choice and suggest broader implications for ongoing feminist movements.
Keywords: biomedicine, choice, direct-to-consumer advertisements, feminism, 
menstruation, pharmaceuticals, rhetoric
Choice, or the illusion of choice, is central to contemporary feminism. Easily aligned 
with activism aimed at empowering women to make decisions about their own lives 
and bodies, choice is ubiquitous, rhetorically powerful, and highly portable. Beyond its 
long and storied history within debates about reproductive rights, choice has gradually 
emerged as a key term to characterize a whole host of gendered issues, from conception 
to work–life balance.1 As such, it presents a rhetorical paradox: It holds the promise of in-
dividual agency but can also be co-opted to promote controversial choices that reinforce 
sexist stereotypes. What are the implications of the rhetoric of choice for ongoing femi-
nist movements? How has choice been deployed in fresh discursive terrains? This essay 
explores these questions in the context of menstrual suppression, a topic that has only re-
cently emerged in public discourse.
Our starting point is simple: Should menstruation be a choice? Not long ago, the idea 
that it could be a choice would have seemed absurd. Menstruation was not a decision to 
be pondered; it was a reality to be dealt with. Yet twenty-first century advances have in-
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troduced pharmaceuticals that make this issue increasingly relevant.2 Oral contraceptives 
have been specifically developed and marketed to limit menstruation. When posited as 
a needless reminder of biological difference, the decision to suppress menstruation may 
seem like an uncontroversial personal choice. For example, in the advertising campaign 
for Seasonique, an oral contraceptive that limits menstruation to four times a year, Du-
ramed Pharmaceuticals implicitly argues that menstruation is an unnecessary event with 
the slogan “Repunctuate your life with fewer periods.” Here, the magic of modern bio-
medical technology presents a simple and yet potentially liberating option: Consume a 
pill and take control of your life.
But what does it really mean to repunctuate one’s life? To punctuate has a double 
meaning—it can designate a periodic interruption (to punctuate a silence with sound; a 
punctuation mark interrupts or divides a sentence from another), or it can mean to ac-
centuate (to emphasize or intensify). Seasonique’s campaign plays on menstrual periods 
as punctuation and promises to correct for the way they interrupt women’s lives. On the 
other hand, some scholars see menstruation as an important part of gendered identity. 
Beyond its physiological purposes, those who promote this perspective believe that men-
struation can be significant to individuals and as a collective experience for women. Fem-
inist political philosopher Iris Marion Young gives voice to the value of menstruation in 
both senses. Her essay “Menstrual Meditations” in On Female Body Experience does not 
deny that menstrual periods disrupt everyday routines but instead argues that disrup-
tions can be valuable reminders to take time out: “Because the event returns monthly, it 
affords an experienced discontinuity that prompts one to look back and forward…. Be-
cause menstrual moments punctuate our lives, they easily orient our self-narrative” (120–
21; emphasis added). If embraced for its reflective possibilities, menstruation can allow 
for a productive indulgence in one’s affective states.
In other work, Young offers a way to understand the relationship between menstru-
ating individuals and collective gendered identity. Borrowing from Sartre, she conceives 
of gender as a series, or a “social collective whose members are unified passively by the 
objects their actions are oriented around and/or by the objectified results of the mate-
rial effects of the actions of others” (“Gender as Seriality” in Intersecting Voices 23). This 
approach offers a middle ground between the problem of defining women on the basis 
of perceived commonalities, which risks essentialism, and the promise of practical polit-
ical action that necessitates seeing women as a group in order to conceptualize oppres-
sion on a systematic level (Young, Intersecting Voices 13). Using menstruation as a pri-
mary example, Young explains that it is not the biological event that creates a series but 
“rather, the social rules of menstruation, along with the material objects associated with 
menstrual practices, [which] constitute the activity within which the women live as se-
rialized” (Intersecting Voices 28). In other words, menstruation creates a material reality 
that has the potential to connect women, and it may be important to the ways that some 
women imagine themselves as gendered beings. Although not all women menstruate; 
women who menstruate do not do so all of the time; and the experience of menstruation 
varies widely between individuals,3 the assumption of menstrual pain is often cited to sup-
port sexist attitudes that limit all women: 
Women who experience debilitating mental or physical pain at menstru-
ation (despite the easy availability of The Pill and other such remedies) 
are made the prototype for all; and in the face of statistics to the contrary; 
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women are still considered unreliable workers and unstable human beings 
at that time of the month. Thus, menstruation is a factor in the control of 
women by men not only in ancient and primitive societies, where knowl-
edge of physiology is rudimentary at best, but also in our post-industrial 
world. (Delaney et al. 3–4)4 
As a physical and social reality, menstruation is a source of serial connection in Young’s 
sense. Based on this perspective, menstruation is significant not because every woman cel-
ebrates it but because it can serve as the basis for a shared political subjectivity. If menstru-
ation is framed not as a condition that passively defines women but as an active choice that 
individuals may opt out of at will, the potential of this connection is tempered.
These competing perspectives about the value of menstruation do not exist in a vac-
uum. They are representative of broader anxieties concerning gender, choice, and bio-
medicine. Although it has been called “strategic for women’s liberation,” biomedicine 
is also “strategic to women’s oppression” as a source of sexist ideology and discrimi-
nation (Ehrenreich and English 5). Feminist scholarship has been pivotal in identifying 
moments of medicalization, when social issues are turned into medical problems and 
bodily differences are cast as diseases or illnesses that one can choose to treat (Lorber 
and Moore 6, 65). Recent technological advancements have created new opportuni-
ties to medicalize women’s bodies, and new occasions to exercise choice, especially in 
reproductive matters such as menstruation, conception, and childbirth. When medi-
cal professionals operate under the assumption that the male body is the norm, wom-
en’s health has the potential to become pathologized, overmedicalized, and subject to 
unnecessary technological intervention. As a result, there have been calls for greater 
patient empowerment, informed consent, and medical knowledge rooted in per-
sonal experience (Willard; Hayden). Yet shifts toward patient-directed health care are 
not without vulnerabilities. Any movement toward greater patient empowerment in 
health care has to contend with a complex web of industry-driven discourses. A host 
of drugs and procedures are now marketed to go beyond what is medically necessary; 
we have the ability to use “enhancement technologies” to make ourselves “better than 
well” (Elliott). We can google our way to a WebMD diagnosis and are encouraged to 
script conversations with health care providers when we see ourselves in pharmaceu-
tical advertisements. Pharmaceuticals increasingly offer women the “choice” to solve 
whatever ails their bodies, even while the nature and gendered meanings of those ail-
ments are in flux (Zita 68).
This essay draws attention to the ways oral contraceptives are now being marketed as 
medical technologies that materially and discursively transform menstruation into a per-
sonal choice, thus circumventing discussions about its cultural value.5 I consider the di-
rect-to-consumer (DTC) advertising campaigns of four oral contraceptives approved by 
the U.S. Food and Drug Administration (FDA) to limit menstruation: Bayer Healthcare 
Pharmaceutical’s Yaz, Warner Chilcott’s Loestrin, Duramed Pharmaceutical’s Seasonale, 
and its second-generation brand name, Seasonique.6 DTC advertisements are public texts 
that showcase how expert discourses “draw on the shared pools of language and imagery 
and argumentative strategy that are available to members of the more general culture” 
(Lyne and Miller 170).7 Such advertisements seek to inform and shape consumer attitudes 
about drugs, and are highly interactive, dynamic texts that are regularly revised in re-
sponse to consumer demand and FDA warnings.8 To analyze the rhetorical construction 
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of menstruation as a choice, I examined the visual and textual components of each phar-
maceutical’s Web-based campaigns from 2006 to 2010, a time period when DTC advertis-
ing of these products was at its height.9 Early iterations of the campaigns provide partic-
ularly rich artifacts for analysis, as they ventured into the relatively uncharted territory of 
crafting arguments about the ability to suppress menstruation.
My analysis is informed by rhetorical studies of medicine and feminist rhetorical 
criticism. Rhetorical analysis plays an important role in exploring whether it is possible 
or desirable to hold on to bodily difference amidst rapid biomedical development, al-
lowing communication scholars to “pos[e] questions that are prior to the questions typ-
ically posed by health researchers” (Segal, “Rhetoric of Health and Medicine” 228). In 
decoding the process of negotiation and translation amongst culture, biomedicine, and 
industry, such analysis can highlight disparate lines of argument, identify the stakes, 
and mediate the conflation of medicine and values in biomedical controversies (Lyne 
8).10 Feminist rhetorical criticism is particularly well suited to study choice within the 
campaigns because allowing “people to understand that they have the capacity to claim 
agency and act in the world as they choose” is its raison d’être (Foss 157). As Sonja K. 
Foss explains, “Gender is a culture’s conception of the qualities considered desirable 
for women and men, a construction created and maintained through various forms of 
rhetoric. In feminist criticism, then, the focus is on the rhetorical process by which these 
qualities come to seem natural and ways in which that naturalness can be called into 
question” (157).
Feminist rhetorical criticism enables us to see how the process can be inverted, as the 
DTC advertisements present menstruation as an undesirable condition for women that is 
unnecessary, unnatural, and detrimental to one’s true identity. I trace how each campaign 
encourages women to make the choice to repunctuate (accentuate) their lives with men-
strual suppression, finding that such discourses (a) appeal to agency and personal choice 
using a post-second-wave rhetoric of feminine empowerment or (b) co-opt second-wave 
feminist rhetorics by conflating the choice to alleviate unwanted pregnancy provided by 
access to oral contraceptives with the choice to alleviate menstrual symptoms today. Ab-
sent from these appeals, of course, is a consideration of how menstruation could be seen 
positively. In this case, feminism itself may be repunctuated (interrupted) as “choice” fa-
cilitates a sense of agency over one’s own body but risks simultaneously reinscribing pa-
triarchal beliefs about menstruation.
To Menstruate or Not to Menstruate? The Choice Is Yours
In their book Contemplating Maternity in an Era of Choice, Sara Hayden and D. Lynn 
O’Brien Hallstein underline the centrality of choice in public discourse: “Choice is part of 
the contemporary lexicon, a term that, to greater or lesser extent, shapes and is shaped 
by women’s and men’s (reproductive) lives” (xxviii; emphasis in original). Although it 
is often associated with feminism, choice remains a highly disputed term. Some hail the 
freedom to exercise choice—any choice—as the defining factor of pluralistic post-second-
wave feminism (Baumgardner and Richards 450; Snyder-Hall). Others critique the ways 
that choice has been depoliticized to support practices that reentrench traditional gender 
roles, counter second-wave feminist gains, and sever ties to collective activism (Fixmer-
Oraiz 42–43; Ferguson; McCarver; O’Brien Hallstein). A number of studies have made 
M a r k e t i n g  M e n s t r u a l  s u p p r e s s i o n  t h r o u g h  t h e  r h e t o r i C  o f  C h o i C e     271
clear that the rhetoric of choice has the potential to both empower and discipline in a 
number of reproductive matters such as contraception, conception, childbirth, and work–
life balance (see Hayden and O’Brien Hallstein, esp. Fixmer-Oraiz). Interestingly, rhet-
orics of choice and empowerment have also been used to mediate between acceptable 
and unacceptable bodily alteration practices, including plastic surgery and female geni-
tal “cosmetic surgery” (Jordan; Braun). Of course, the ability to access and exercise choice 
is always influenced by a number of factors, including “relationships with others, men-
tal and physical health, race, sexual orientation, and economic status, public and work-
place policies, developments in reproductive technology, and the social norms and mes-
sages communicated to women about the appropriateness of becoming mothers (or not)” 
(Hayden and O’Brien Hallstein xvii).11 
Given the pervasiveness of choice in contemporary culture, it is unsurprising that 
the DTC campaigns analyzed here attempt to make menstruation itself a choice. But this 
raises the question: What exactly does choice mean in the context of menstruation, and 
what is at stake for women’s lives? Philosophically, feminine corporeality has been con-
ceptualized as an uncontrollable flow in Western culture, a permeable boundary that 
leaks and bleeds (Grosz 203–204). The idea that the literal and figurative flow of wom-
en’s bodies needs to be contained is nothing new. Historically, menstruation has not func-
tioned within the realm of choice—it was a shameful process that girls and women were 
taught to conceal. As Roseann Mandziuk illustrates, this message surrounding menstrua-
tion can be traced to sanitary napkin advertising in the early twentieth century. Biomedi-
cal and consumerist discourses about menstruation have long existed in a symbiotic rela-
tionship, where “medicine contributes the impression that menstruation renders women 
offensive and incomplete; advertising discourses, in turn, offer products to compensate 
for this inadequacy, women’s perpetual ‘problem’” (Mandziuk 42). Before the advent of 
pharmaceuticals marketed to suppress menstruation, the rhetoric of choice was limited 
to choice about what kind of personal hygiene product (sanitary napkins, tampons, etc.) 
should be used to best conceal it. In the analysis that follows, I trace how such oral contra-
ceptive campaigns introduce a whole new era of menstrual concealment that urges indi-
viduals to make the choice to empower themselves by addressing menstrual symptoms, 
enhancing their lifestyles by shortening their monthly periods, or reclaiming lost time by 
reducing the number of periods they experience each year.
Yaz: “We’ve Got the Right to Choose”
Bayer Healthcare Pharmaceuticals’ oral contraceptive, Yaz, is the first birth control 
pill approved by the FDA to address premenstrual dysphoric disorder (PMDD), a con-
dition of heightened emotional and physical stress occurring up to ten days before men-
struation. It is differentiated from but sometimes described as a severe form of premen-
strual syndrome (PMS).12 Bayer enlisted the help of the global communications agency 
MediaEdge: Cia (MEC) to prime consumers about PMDD before the official release of the 
pharmaceutical. With the stated goal of “activating girl power,” MEC created a multime-
dia campaign to “engag[e] with young women about confidential health choices through 
music and online content.” Girl power assumes a level of gender equality not present in 
second-wave feminist efforts, urging young women to tap into their (already) empow-
ered feminine selves (Hains 98). Not to be confused with the “grrrl power” promoted by 
feminist punk bands, “girl power” was propagated through 1990s’ popular culture (think 
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Spice Girls, not Bikini Kill). In fact, by 2002, the idea of girl power was so mainstream 
that it was added to the Oxford English Dictionary, which describes it as “a self-reliant atti-
tude among girls and young women manifested in ambition, assertiveness, and individ-
ualism” (BBC News). Entangled in commercialization and popular culture, some argue 
that girl power is a characteristic feature of postfeminism. Postfeminism, as defined by 
feminist media scholar Angela McRobbie, is an “active process” that undoes second-wave 
feminist accomplishments even while “appearing to be engaging in a well-informed and 
even well-intended response to feminism” (255).13 Bayer’s DTC campaigns about PMDD 
and Yaz used appeals to empowerment to position menstrual symptoms as a problem 
that strong women choose to fight back against.
MEC notes that feminine empowerment was a cornerstone of the campaign, which 
operated under the driving insight that “women want to be in control of their bod-
ies … yet they believe that severe PMS is normal and silently accept debilitating symp-
toms” (MediaEdge: Cia). Their solution was to create a three-pronged “unbranded ed-
ucation campaign.”14 First, they hired an Australian band, The Veronicas, to record 
Twisted Sister’s 1984 top-40 song, “We’re Not Gonna Take It.” The band, which has 
been called postfeminist and even post-postfeminist, was the perfect choice for the cam-
paign: The young, hip, Origliasso sisters projected an alternative brand of girl power 
but were still willing to make guest appearances at the Miss USA pageant (Haruch). 
The former glam-rock hit took on new meaning when sung by The Veronicas. A stylis-
tic and sonorous update to second-wave feminist anthems such as “I Am Woman, Hear 
Me Roar,” “We’re Not Gonna Take It” was transformed. No longer was the song in-
tended to target patriarchy; instead, it addressed the bloating, headaches, and depres-
sion that sometimes accompany menstruation. Lyrics such as “we’ve got the right to 
choose” make menstrual symptoms a choice that the consumer can opt out of by opting 
in to use Yaz. If menstruation is a choice, and women have the right to choose, why not 
exercise that right? Why just “take it”?
The second element of the MEC’s unbranded campaign was a Web site, wngti.com, in-
tended to drum up interest in PMDD before the unveiling of the Yaz campaign.15 Out-
lined in bright pink and decorated with hearts, the Web site allowed consumers to get a 
behind-the-scenes peek at The Veronicas and make a connection between the lyrics and 
their feelings about menstruation: The band suggests that their fans and “women every-
where … should take action to live the best life they can, emotionally and physically” 
(wngti.com). Visitors obtained a free download of the song by entering the code “under-
standpmdd” and their e-mail into a form on the Website, and could enter a video contest 
with their own a capella version of the song. Once users requested to download the song, 
they were prompted to visit another Web site, UnderstandPMDD.com. MEC reports that 
the song was downloaded more than 350,000 times and that 42,000 people visited the 
Web site over a three-month period (MediaEdge: Cia).
Of those 42,000 users, 70% continued on to the third and final component of MEC’s 
campaign: the companion Website, UnderstandPMDD.com (MediaEdge: Cia). The Web 
site provided consumers with information needed to self-diagnose PMDD. Women were 
told that they should understand their monthly symptoms and were asked to record their 
experiences in a “body diary” to help evaluate the severity of their PMDD symptoms. 
Here, tracking one’s symptoms is framed not as bodily regulation but as a record of what 
one can choose to overcome. Highlighting the loss of time that PMDD sufferers experi-
ence, visitors to the Web site were asked: “Do you feel like half of the month isn’t yours?” 
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When framed as a condition that robs them of their right to live full lives, the choice to 
suppress menstrual symptoms seems like an easy one to make.
These messages are supported by the images on the Understand PMDD site. PMDD 
can be physically and emotionally debilitating, and pharmaceutical intervention allows 
women to fight back. Each image invokes the idea that women need to take control, mo-
bilizing various self-defense techniques against the PMDD symptoms that are waiting to 
attack. In one image, a woman in workout gear stands in ready position, her hands clad 
with boxing gloves, and stares straight into the camera, her teeth gritted, and her mouth 
in a half-smile. Across her waist is the now familiar lyric: “We’re not gonna to take it.” 
Another image shows the same woman doing a karate kick, shattering a banner labeled 
“mood swings.” The next page shows a woman in a dress hitting “irritability” with a 
lamp. The “Talk to Your Healthcare Professional” and “FAQ” pages include images of 
women squeezing the banner that says “food cravings,” and pushing back against “fa-
tigue” (UnderstandPMDD.com). That the campaign decided to focus on self-defense is 
telling as we attempt to decode the relationship between the pharmaceuticals and fem-
inist rhetoric. Self-defense has long been associated with feminist movements in the 
United States, in that it provides a mechanism to fight back against gender-based vio-
lence. Self-defense classes for women were established and popularized during the sec-
ond-wave women’s movement. Yet as Whitney Walker’s contribution to the popular 
third-wave volume Listen Up! Voices from the Next Feminist Generation makes clear, em-
powerment through self-defense continues to be a potent feminist strategy for contempo-
rary women. Walker found her own “feminist awakening” through self-defense courses 
after she was made to feel vulnerable by a male flasher and came to realize that “self-de-
fense is becoming as important to my generation of the women’s movement as it was to 
my mother’s” (128). Whereas self-defense was made meaningful in the past because it al-
lowed women to resist forced subordination to violent perpetrators, the UnderstandP-
MDD.com Web site urges women to resist subordination to their own bodies. PMDD 
symptoms are figured as the attackers, and Yaz becomes a weapon of individual em-
powerment, functionally co-opting feminist rhetorics of self-defense to combat violence 
against women.
After cultivating an audience with MEC’s efforts, Bayer Healthcare Pharmaceuticals 
followed up with the official launch of the Yaz Web site and television advertisements. 
The Web site promised that women taking Yaz could go “beyond birth control.” Con-
sumers could not only prevent unwanted pregnancies but also have shorter, lighter peri-
ods, and fight back against menstrual pain such as “anger, irritability, depressed moods, 
feeling anxious, bloating, change in appetite, headaches, and muscle aches … and acne” 
(Yaz-us.com). Two television advertisements, “Not Gonna Take It” and “Balloons,” were 
launched in 2008. Both featured The Veronicas’ songs as background music (“Balloons” 
also featured the song “Goodbye to You”). The “Not Gonna Take It” spot adapted the im-
ages of women “fighting” PMDD symptoms from the UnderstandPMDD.com Web site 
for television audiences, while the “Balloons” ad showed women “letting go” of PMDD 
symptoms labeled on balloons, sending their menstrual pain and suffering away.
In 2008, the FDA issued Bayer an official warning for the television advertisements. 
The campaign was charged with misleading consumers “from a public health perspec-
tive, because they encourage use of YAZ in circumstances other than those in which the 
drug has been approved, over-promise of the benefits and minimize the risks associated 
with YAZ” (Abrams 1). The FDA letter to Bayer’s president and chief executive officer Re-
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inhard Franzen detailed a number of violations, including that the advertisements used 
the acronym PMDD but never spelled out the proper name of the condition, increasing 
the likelihood that consumers would conflate it with PMS; that it indicated Yaz could be 
used to treat acne of any severity level; that in suggesting consumers could “say good-
bye” to their symptoms completely by letting go of balloons or kickboxing away the 
symptoms, they overstated Yaz’s effectiveness in treating PMDD; and finally, that the 
risks of taking Yaz were minimized due to “distracting visuals, numerous scene changes, 
and other competing modalities such as background music” (Abrams 6). Bayer was then 
told to air corrective advertisements to set the record straight.
By incorporating a “postfeminist” band to play background music, appealing to a 
“girl power” sensibility, and encouraging women to (literally) fight back against PMDD, 
Bayer positioned Yaz as a means of individual empowerment. Instead of collectively or-
ganizing to address social ills, women are encouraged to see menstrual suppression as a 
right that they can and should freely choose to exercise to gain control over their lives. As 
the next section reveals, another campaign strategy continued this message of individual 
empowerment but also suggested that menstrual suppression is not only a right—it is a 
proactive lifestyle choice.
Loestrin: Choosing Shorter Periods
Warner Chilcott’s Loestrin24fe is an oral contraceptive pill that shortens the length of 
menstrual periods from an average of five to seven days to three days. Instead of fram-
ing (pre)menstrual symptoms as obstacles to fight against, a narrative approach articu-
lated menstrual suppression as a choice to enhance one’s lifestyle. The initial campaign 
included Web site and television advertisements that placed a particular emphasis on the 
shorter length of periods offered by the drug. For example, visitors to the Web site were 
greeted with a banner that read “The pill with a short period.” As readers scrolled down 
to read answers to such questions as “Are shorter periods ok?” and “How does Loes-
trin24fe shorten my period?,” they were told to click on a link labeled “The short way 
back up” to return to the top of the page (Loestrin24.com). 16 
Perhaps the most provocative element of the Loestrin Web site was the elaborate story 
told about Cammie, the character on the drug’s television ads. The television commer-
cial, which was also available on the Web site, plays out a thirty-second narrative about 
a White, hip, cosmopolitan woman seen on a laptop, typing “how to say so long to a pe-
riod that’s too long” into a search engine. The commercial does not get into great detail, 
but we see different shots of Cammie enjoying life in her apartment, hanging out with her 
dog and then with a man. However, visitors to the Web site were given more information 
about how to interpret the television ad: They could click on a link to “meet” Cammie. 
This link took potential consumers to the very detailed world of Cammie, where they 
could learn about Cammie’s life, friends, favorite bands, hobbies, and interests. Consider 
this excerpt: 
Cammie is an aspiring textile designer in her mid-twenties. She works out of 
a shared studio in the same building where she rents her loft apartment in Al-
phabet City, a funky downtown neighborhood in NYC…. Cammie’s taste in 
just about everything is eclectic. Her clothes. The way she decorates her apart-
ment. Her friends. Most definitely her taste in music. Even the guys she dates. 
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She’s got this amazing instinct for putting together the most interesting, and 
more often than not offbeat, people and things. Speaking of guys, Cammie’s 
just met Ryan, a production assistant and part-time lead singer in a local alter-
native rock band. He’s definitely cute and a lot of fun to be with, but Cammie 
just wants to be friends. You see, she just broke up with her college boyfriend, 
Kevin, and she’s still too tender from it to want to jump right back into a seri-
ous relationship. (Loestrin24.com, “Cammie’s Story”)
Cammie is positioned as an atomized individual whom we see in relation to her 
work, romantic relationships, and her pet. The Web site uses an exhaustive narrative 
appeal designed to make readers feel as if Cammie is the type of person that they can 
identify with. Loestrin’s manufacturers make their target demographic very evident: 
White, young, single, heterosexual women interested in music, fashion, and upwardly-
mobile urban living.
The lifestyle norms that characterize this demographic demand a calendar unpunc-
tuated by the nuisance of lengthy menstruation. Cammie’s story explains how taking 
Loestrin can guarantee a vibrant social life by highlighting the significance of the num-
ber three and the word “short” in her life. We learn that Cammie’s favorite number is 
three: she was born on 3/3, she is the youngest of three sisters, and the new guy she is 
dating has three threes in his phone number. Perhaps most incredibly, even her dog’s 
story corresponds to the shorter periods that Cammie will soon experience on Loestrin. 
That’s right: Cammie’s dog is named Shorty. Shorty is described in great detail, and there 
are even links to the Basset Hound Club of America and the American Kennel Club em-
bedded in “Shorty’s story” (Loestrin24.com, “Cammie’s Story”). The campaign goes to bi-
zarre lengths to hammer home the message: “So, you can imagine how lucky Cammie felt 
when she discovered that Loestrin 24 Fe is a low estrogen birth control pill with periods 
that last on average less than 3 days.”
Loestrin’s narrative approach may seem over the top, but it fits perfectly with the strat-
egy of creating an identity for the consumer rooted in the individual choice to limit men-
struation. Narratives often play fundamental role in constitutive rhetoric, opening “diag-
etic spaces, story spaces, which are meaningful because they produce identification with a 
point of view” (Charland 617–18; emphasis in original). Narrative appeal in advertising is 
particularly important in a world dominated by overpersonalization. In positioning Cam-
mie as a “normal” young woman who does not want to be burdened by the usual length 
of menstrual periods, Loestrin’s DTC advertisements create diagetic spaces that facilitate 
identification between the consumer and a fictional character. The “story spaces” created 
by Cammie’s online biography mimic online social networking Web sites, where users 
can go to find out specific details of their friends’ lives and oversharing is a norm. Con-
sumers can imagine her as a real person, a model of what they could be if they also made 
the choice to use Loestrin.
There is an implicit assumption that women should have sexual freedom in the cam-
paign; Cammie clearly isn’t ready to settle down, and the Pill assures that she doesn’t 
have to. Yet Loestrin’s ability to prevent unwanted pregnancies is secondary to its claim 
to shorten menstrual periods. Like Yaz, the campaign draws from post-second-wave fem-
inist rhetorics by focusing on individual choice and consumer culture. As Helene Shugart, 
Catherine Eggley Waggoner, and D. Lynn O’Brien Hallstein explain in their investigation 
of appropriations of third-wave feminism, “Being empowered in the third-wave sense is 
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about feeling good about oneself and having the power to make choices, regardless of 
what those choices are” (195). The Loestrin DTC campaign co-opts this sense of choice, 
moving beyond the third wave and into a postfeminist rhetoric of choice that divorces in-
dividuals from a greater sense of social justice or feminist history. It stresses that individ-
uals can choose to have a lifestyle like Cammie’s through pharmaceutical intervention. 
Of course, the campaign is not about providing all women with choices. Rather, the fo-
cus on individual lifestyle choices reaffirms sanitized, White, middle-class social and ca-
reer norms and ignores the very real obstacles encountered by those who do not have ac-
cess to this type of lifestyle (Zita 68). The DTC campaigns for Duramed Pharmaceuticals 
similarly promote menstrual suppression as a way to enhance individual lives, offering 
women the option to empower themselves by reclaiming time lost to menstruation.
Seasonale/Seasonique: Choosing Fewer Periods
While Yaz promises to combat menstrual symptoms and Loestrin promises to limit 
the number of days per month a woman spends menstruating, Seasonale and Seasonique 
boast the ability to limit the number of periods experienced each year. As the first men-
strual suppression drug to be approved by the FDA, Seasonale received much media at-
tention (Fried; Payne).17 This oral contraceptive reduces the occurrence of menstruation 
from thirteen times a year on a traditional birth control pill to four times a year (hence 
the reference to the seasons in both drug names).18 Drawing on the idea that menstrua-
tion impedes a “normal” life, these campaigns employed some of the themes of empow-
erment and lifestyle enhancement evident in the marketing strategies discussed so far. 
Unique to Seasonale and Seasonique, though, is a focus on ensuring that schedules and 
life trajectories are not disrupted by menstruation.
With its focus on fewer periods, the Seasonale campaign focused on the theme of 
time loss as an argumentative topos. Clearly attentive to the concerns that women may 
have about the dangers of menstrual suppression, two slogans, “Seasonale: the daily 
birth control pill that’s the same but different” and “Fewer periods, more possibilities,” 
stressed that this choice would be an easy change with significant benefits. Visitors to 
the Seasonale Web site were encouraged to use an interactive personal planner where 
they could “plan events like vacations, business travel, romantic encounters, and fam-
ily reunions” with the luxury afforded by more time between menstrual periods (Seaso-
nale.com). By identifying the benefits that women might garner from fewer periods, the 
campaign appealed to other activities that consumers might see as central to their iden-
tity. They urged women to define themselves by romantic encounters and vacations, 
rather than by menstruation: their schedules don’t need to be flexible as long as their 
bodies are open to pharmaceutical intervention. There was also an attempt to win over 
skeptics by asking them to imagine their lives undisrupted: “Not yet a SEASONALE® 
user? You can still use the Personal Planner to plan activities and see when your inac-
tive Pill dates would happen if you were taking SEASONALE®” (Seasonale.com, “Sea-
sonale Personal Planner”).
Women seeking online information about menstrual suppression could also visit a 
companion Web site FewerPeriods.com, run by Duramed Pharmaceuticals. At this site, 
readers were greeted with the images of three young, confident-looking women and an 
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older—and presumably wiser—woman with a lab coat and a stethoscope around her 
neck. The Web site informed visitors that they had come to the right place to uncover 
the “truth about fewer periods,” with answers to such questions as “Why are fewer pe-
riods possible?”; “Is it safe?”; “Will it affect fertility?”; and “What do the experts say?” 
(FewerPeriods.com). Women were encouraged to talk to their health care professionals 
about having fewer periods by creating a free, personalized discussion guide to take to 
their office visit. Essentially, a pharmaceutical company was scripting the conversation 
that patients might have with their doctors so that the doctor would write a prescrip-
tion for their product.
In May 2007, an advertisement for Duramed’s Fewer Periods Web site ran in Shape 
magazine (Duramed Pharmaceuticals). The four-page ad begins with the image of a 
young blonde woman on the beach, throwing her hands up in glee and trying to twirl 
two Hula-Hoops around her hips. Why does this woman have two Hula-Hoops? The two 
Hula-Hoops could easily represent the well-known desire to “have it all”: a rewarding 
balance between work and home activities. However, in this formulation, it more likely 
represents the balance between everyday life and the management of her menstruation. 
The accompanying text asks readers, “Entertaining the possibility of fewer periods? It 
may be possible if you are on hormonal birth control. Most women agree that life would 
be nicer if they could have fewer periods.” In other words, use our product and you will 
be able to manage your two Hula-Hoops with ease.
The ad then goes on to give a brief history of the Pill under the heading Periods in the 
21st Century. As the reader turns the page, they see a medical advice column, “Ask Dr. 
Sulak,” in which the doctor answers questions about health concerns and convenience 
factors involved in making the decision to have fewer periods. “Cathy,” for instance, says 
she does not want her period to happen while she is on her honeymoon but is afraid that 
she won’t be able to get pregnant in the future if she suppresses it. Dr. Sulak puts her 
mind to rest—getting fewer periods on birth control will not affect her ability to get preg-
nant once she ceases to take the medication. And if “Cathy” wasn’t convinced by Dr. Su-
lak’s advice alone, the ad includes an image of a young, blonde, White mother smiling 
and holding up a young girl to confirm postsuppression fertility, visually assuring wor-
ried women that a future of happy motherhood would not be altered.
The final page is perhaps the most revealing of the normative assumptions behind the 
ad. On the left-hand side of the page, there is a sidebar called “Turning Points in Con-
traception” that contains bullet points showing “new phases” in a woman’s life: start-
ing a new relationship, getting married, and having a baby. Each of the three phases 
is accompanied by a morsel of advice: a woman in a new relationship will want to re-
evaluate her birth control; an engaged woman will be wary about her period “interrupt-
ing” her honeymoon; and a new mother must realize that her “time is not [her] own, and 
[she] will need to evaluate whether refilling a prescription every month and dealing with 
monthly cramps [will interfere] with [her] new responsibilities.” In collapsing women’s 
lives down to these three phases, the advertisement defines women by their roles as girl-
friends, wives, and mothers; never mind if a woman is not in a relationship with a man or 
does not want to, or cannot, have children. The accompanying image on this ad page is a 
light-skinned African American woman, standing in a field with her head tilted upward, 
a smile on her face (Duramed Pharmaceuticals). The ads suggest that consuming Seaso-
nale can enable individual women to better fulfill traditional gender roles.
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In 2009, the campaign evolved to promote the next generation version of the drug, 
Seasonique. The Seasonique Web site, Seasonique.com, maintained much of the content 
previously available on the safety and convenience of limiting menstruation to four times 
a year. It also maintained a focus on reclaiming loss time: the new campaign adopted a 
new slogan, “Repunctuate your life with fewer periods.” Recalling the double meaning 
of punctuate discussed earlier—either as a periodic interruption or an intensification—we 
can see that the strategy is to convince women that menstruation is an unwanted periodic 
disruption but that pharmaceutical intervention can accentuate their otherwise wonderful 
lives. The Seasonique Web site was unique in that it explicitly used historical arguments 
to differentiate contemporary women from their predecessors. Constitutive rhetoric con-
structs individuals through three distinct modes of identification: collective identity, as 
subjects in history, and as subjects who act in sync with their historical identities (Char-
land 617). Like the girl power invoked in the Yaz campaign, it references feminist history 
to demonstrate how women have moved beyond second-wave feminist concerns with co-
alitional solidarity. Consumers need not experience monthly menstruation for the reflec-
tive period or as a point of serial connection with other women. Yet the Seasonique cam-
paign positions the unpunctuated lifestyles enabled by menstrual suppression as the next 
step in a feminist progress narrative. Contemporary women are urged to take Seasonique 
so that their lives will be minimally disrupted, without the pain or nuisance of menstrua-
tion that previous generations of women had no choice but to endure. The campaign con-
structs individuals as subjects in history who can choose to act in sync with and distin-
guish themselves from their feminist foremothers.
By clicking on “The Real Story of the Pill,” visitors to the Web site read a historical 
narrative aimed at persuading women that there is no medical need for monthly periods. 
But it was not a lecture: A history of oral contraceptives was told with a snarky, sarcas-
tic flair made popular by commodity-driven, post-second-wave feminist publications like 
Bust magazine. The history included a timeline that stretched back to Genesis, making 
historical pit stops along the way. In 384 BCE, for example, we learned that “Old Greek 
men” were doing “Old Greek things” when Aristotle, “one of the smartest men in the his-
tory of history, decides it’s a good idea to use natural chemicals … as a spermicide.” Fast-
forwarding to first-wave feminism in the United States, the timeline touched down on 
milestones in the development of birth control such as in 1873, when “Congress’ ques-
tionable taste in porn becomes apparent when they classify birth control as obscene ma-
terial” and Margaret Sanger’s 1912 dream of a “magic pill.” Biomedical advances such as 
the discovery of progesterone were charted with built-in jabs at menstrual stereotypes: 
“1928: Progesterone, one of the primary hormones that causes the menstrual cycle, is dis-
covered. Science rejoices. Then cries a little bit. Then rejoices again. Followed by more 
laughter and fits of crying before finally deciding to take it all out on her boyfriend” (Sea-
sonique.com, “The Real Story of the Pill”).
The pivotal date on the timeline is 1954, when Gregory Pincus and John Rock invent 
the Pill. The historical narrative promoted by Duramed here is that to appease Rock’s 
church, they built a “fake period” into the oral contraceptive regimen. Second-wave fem-
inist accomplishments such as the integration of more women into the workplace, the 
popularization of the Pill, and changing gender roles in the family temporally coincide 
on the continuum with FDA approval of oral contraceptives. “Today” was marked on 
the timeline with an acknowledgment that the recent FDA approval of extended pill reg-
imens was right in step with other accomplishments, conflating the sexual liberation and 
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alleviation of unwanted pregnancy provided by the Pill in the 1960s with personal liber-
ation and alleviation of unwanted menstruation today because women can “repunctuate 
their lives with four periods a year.”
The “real story of the pill” provided consumers within a grand narrative of overbear-
ing men versus smart, organized women fighting for additional rights such as the ability 
to make their own decisions about oral contraceptives. It offered a way for contemporary 
women to acknowledge themselves as subjects in feminist history who, to act in accor-
dance with that history, need not collectively organize against patriarchal views towards 
menstruation. If women in the 1960s organized for access to the Pill, wouldn’t they also 
embrace advancements in medical technology that offer individuals the choice to sup-
press menstruation today? Seasonique’s marketing strategy borrowed from reverence for 
the accomplishments of second-wave feminist activism but promoted a pharmaceutical 
that would erase monthly menstruation as a link between women. It took the message of 
individual empowerment through the reclamation of one’s time introduced in the Seaso-
nale campaign and embedded it within a broader feminist historical frame.
Punctuated Lives, Possible Futures: Feminisms and the Rhetoric of 
Choice
Although they have different points of emphasis, the campaigns for Yaz, Loestrin, 
Seasonale, and Seasonique all draw attention to women’s empowerment and agency over 
their own bodies and lives. For women who experience debilitating pain during men-
struation, or those who do not intend to become pregnant, this pharmaceutical interven-
tion may be quite liberating (Edelman). Transmen may find menstrual suppression use-
ful as a part of hormonal therapy. Some women in the military have expressed an interest 
in menstrual suppression during deployment (Trego; Powell-Dunford et al.). In each of 
these cases, menstruation and its gendered baggage may feel unnecessarily restrictive. 
To be sure, DTC advertisements are first and foremost concerned with selling a product, 
and they are operating within a long tradition of marketing discourses borrowed from so-
cial movement rhetorics. Yet insofar as choice and agency are fundamental to post-sec-
ond-wave feminisms, the rhetorical construction of choice surrounding menstrual sup-
pression should be applauded for articulating and amplifying a choice where one did not 
seem to exist before. These discourses have the potential to repunctuate (productively 
disrupt or rupture) a single feminist narrative that assumes a monolithic relationship be-
tween individuals and menstruation.
However, this study also highlights some troubling moves within the DTC campaigns. 
First, the campaigns studied here posit menstrual suppression as a choice that should be 
exercised by all women or as a choice befitting a particular lifestyle. The Yaz and Sea-
sonique slogans employ a strategic ambiguity in which anyone becomes a candidate for 
menstrual suppression. Who exactly, is the “we” in “We’re not gonna take it”? Whose life 
should be “repunctuated” “with fewer periods”? The Loestrin and Seasonale campaigns 
are narrow in their respective representations of mostly young, White, heterosexual, mid-
dle-class women and those who expect their life courses to include heterosexual dating, 
marriage, and childbirth. This is problematic in that the campaigns seem to either mass-
produce a need for menstrual suppression where it may not exist or reproduce limited 
gendered scripts. My concern is that those who may find the choice to suppress menstru-
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ation most empowering— those with debilitating menstrual pain, those who do not in-
tend to become pregnant, trans men, and women in the military, among others—do not 
seem to be the target audiences for these advertisements.
Second, these discourses assume that any debate about the value of menstruation has 
already been settled. In constructing menstrual suppression as a route to individual fem-
inine empowerment, discussion of the broader cultural implications of that choice are 
elided. The campaigns suggest it is menstruation, rather than sexism, that holds women 
back today. This is significant, as these discourses aim to transform how contemporary 
women, and particularly young women, understand themselves as individuals bene-
fitting from past feminist gains. The rhetoric of choice links their products to previous 
women’s movements, giving menstrual suppression an implied authorization. This posi-
tion was encapsulated by Candace Bushnell, Sex and the City creator and spokesperson for 
Seasonale, when she said: “When you think about what women have accomplished with 
13 periods a year, [t]hink about what we can accomplish with only four. We have come 
a long way, but we’ve only just begun” (qtd. in Gettelman). When DTC campaigns cast 
menstruation as an individual choice, they artfully bring the topic of menstruation into 
public discourse without really talking about it, urging a seamless acceptance of the non-
menstruating body as a new norm for women. But this has long been the norm within in-
stitutions that cater to male bodies.19 Will the choice to menstruate become the truly rad-
ical choice of the future? In a world where menstrual suppression predominates, will it 
be an individual’s fault if she opts to experience menstrual symptoms (and consequently 
must take bathroom breaks, take the day off of work, etc.)? I am apprehensive of any new 
“choice” that seems to replace one restrictive norm with another, punishing those who 
do not exercise that choice. Absent a frank discussion about what menstrual suppression 
means for women on a societal level, feminism may be repunctuated (interrupted or hin-
dered) by these campaigns.
How, then, might we envision this issue in a way that repunctuates (accentuates or in-
tensifies) a feminist concern for choice and the “emancipation of all subjects from unnec-
essarily constraining gender stereotypes” (Bruner 9)? This approach entails an acknowl-
edgment that the relationship between menstruation and gendered identity remains 
unsettled. There is still a fruitful debate to be had about whether these pharmaceuticals 
are a valuable feminist technology, and it needs to be fleshed out outside of advertising 
discourses. We need a conversation about the value of menstruation that affirms women 
and considers menstrual suppression in the service of gender emancipation.20 Some may 
argue that menstruation continues to be an important serial connection between women, 
one worthy of celebration.21 How significant is the link created by menstruation—actual 
or assumed—to ongoing feminist movements? Others may argue that this serial connec-
tion is activated only if negative cultural attitudes about menstruation persist and suggest 
other connections around which feminist political subjectivity can be based. Today, there 
is an emerging third-wave feminist branch of “menstrual activism” that positively reval-
ues menstruation through public campaigns, art, and poetry (Bobel; See also Chesler; Mc-
Donald). Gender diversity, including the recognition that not all who identify as women 
menstruate and not all who menstruate identify as women, is central to this movement 
(Bobel 159). It is possible to acknowledge that individuals have diverse relationships to 
menstruation and can make personal choices about whether to menstruate without con-
straining sexist stereotypes.
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This study has focused on discourses of menstrual suppression, but it also highlights a 
paradox important to understanding feminism and choice. As it continues to be deployed 
in new discursive terrains, rhetorical analysis is needed to identify moments when the 
rhetoric of choice purports to empower individuals with choices that may actually limit 
possibilities for others. Choices are not inherently good or bad, feminist or antifeminist. 
But any seemingly personal decision also entails a choice about whether to engage in a 
host of attendant concerns (sexism, classism, racism, heterosexism) within a wider web 
of collective relationships.22 To really value choice, then, is to look for rhetorical solutions 
that truly facilitate the exercise of choice for all.
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Notes
1. In the context of abortion, for example, Celeste Michelle Condit explores “choice” as a ideograph in her 
Decoding Abortion Rhetoric (68–99). Catherine H. Palczewski develops a critique of “choice” in favor 
of “reproductive freedom” in her “Reproductive Freedom Transforming Discourses of Choice.” Sara 
Hayden and D. Lynn O’Brien Hallstein’s edited volume Contemplating Maternity in an Era of Choice 
demonstrates the breadth of reproductive issues now defined by rhetorics of choice.
2. Using birth control pills in this way is not new; the “off-label” practice of skipping the placebo or sugar 
pills in a packet has long been deployed to delay menstruation. However, this essay focuses on adver-
tising campaigns that specifically market oral contraceptives for this purpose.
3. In the quest to understand whether there is anything worth saving about menstruation, it is important 
to avoid essentializing the experiences of individual women. Some view menstruation as a painful 
nuisance, some find it a source of empowerment, and still others just see it as a routine part of exis-
tence. The extent to which menstruation is actually meaningful to individuals, as Judith Butler re-
minds us, is varied. Even seemingly material biological differences between the sexes such as men-
struation and pregnancy are always discursively and institutionally predefined by the policing of 
gender norms. In the same way that being biologically female does not guarantee the ability or the 
desire to become pregnant, menstruation is not universal (Butler qtd. in Osborne and Segal). Atti-
tudes toward menstrual pain may be affected by many factors, including age, class, race, sexual pref-
erence, gender identity and expression, and cultural attitudes toward menstruation. These intersec-
tional identities may impact an individual’s attitudes toward menstrual pain in a variety of ways. For 
example, concern about menstrual pain could vary based on an individual’s class status—if a woman 
cannot afford brand name pharmaceuticals, she may not have access to menstrual suppression. Al-
ternately, an individual who does not intend to have biological children may see monthly menstrual 
pain as an unnecessary burden. The DTC advertisements studied in this essay tend to elide these dif-
ferences in their attempts to attract their target consumers (i.e., mostly young women in heterosexual 
relationships).
4. For examples of medical and popular texts on the social history of menstruation see Buckley and Gott-
lieb; and van de Walle and Renne.
5. Though they attracted a flurry of interest when first introduced to the market, limited scholarly atten-
tion has been paid to the rhetorical dimensions of marketing menstrual suppression in pharmaceu-
tical campaigns. For scholarly analyses of menstrual suppression to date, see Andrist; Johnston-Ro-
bledo, Barnack, and Wares; and Mamo and Fosket.
6. Duramed Pharmaceuticals is a subsidiary of Barr Laboratories. Teva Pharmaceutical Industries ac-
quired both in 2008. Despite initial delays from the FDA, a fifth oral contraceptive, Wyeth’s Lybrel 
(also known as Anya) was made available to consumers in 2008. Lybrel promised to stop menstrua-
tion altogether. Because Lybrel had the least-developed DTC campaign during the time period cov-
ered in this study (2006–2010), I have chosen not to feature it in my analysis. However, initial promo-
tional materials for Lybrel made similar moves to the other DTC campaigns: They featured images 
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of relaxed, happy, and healthy women. In one image, a White woman has her hands extended be-
hind her. The wind is blowing through her hair, and her bare feet are slightly lifted off the ground, as 
if she does not have a care in the world and is ready to take flight. She appears in a green field with 
blue skies in the background (Lybrel). The decision to feature the woman in nature may have been in-
tended to signal a move to recast the nonmenstruating body as a new normal, natural way of being.
7. M. Louise Ripley draws on argumentation models from Aristotle to Toulmin to van Eemeren and Groo-
tendorst to make the case that advertisements function as arguments. Other studies, such as Davi 
Johnson (Thornton)’s analysis of the antidepressant Sarafem and Grow and colleagues’ analysis of an-
tidepressants, similarly make the case that DTC advertisements are valuable communication texts.
8. According to Dayna Porter, “Pharmaceutical industry spending on DTC promotion grew from $791 
million in 1999 to $4.8 billion in 2006,” in response to relaxed FDA regulations (51). As much as indi-
viduals like to think that they are immune to the persuasive power of advertising, the economic and 
power dynamics that animate the contemporary marketing landscape make them difficult to avoid 
(Schroeder 164). For specific survey data on the influence of DTC ads, see the FDA’s report, “The Im-
pact of Direct-to-Consumer Advertising” (U.S. Food and Drug Administration).
9. I studied each campaign’s primary Web site: Yaz-us.com, Loestrin24.com, Seasonale.com, and Seaso-
nique.com. These multimedia Web sites were ideal for studying DTC campaigns because they pro-
vided information about each pharmaceutical and included specific persuasive appeals aimed at con-
sumers. Loestrin’s Web site also hosted video clips from the campaign’s television ads. I looked at 
secondary but related Web sites designed to create an audience for the drugs: wngti.com and Under-
standPMDD.com linked consumers to Yaz, while FewerPeriods.com provided information for those 
interested in limiting their periods to four times a year with Seasonale. Finally, I looked at a four-
page print advertisement that ran in Shape magazine in May 2007 because it promoted FewerPeriods.
com (and thus was part of the larger Seasonale campaign). As I note, the heyday of DTC advertising 
of these oral contraceptives occurred between 2006 and 2010. Each Web site or related Web page an-
alyzed is cited internally and in the works cited for this essay, which includes dates accessed. This is 
important because the campaigns were revised over time. The original campaigns analyzed can be 
viewed using Internet Archive’s Wayback Machine (http://www.archive.org). At the time of press, 
these oral contraceptives are still on the market, but their campaigns have been abandoned or scaled 
back considerably.
10. Rhetorical interventions into biomedicine include studies with implications for women patients, such 
as the B-06 lumpectomy controversy (Keränen), the marketing of female sexual dysfunction (Segal, 
“‘Female Sexual Dysfunction’”), and social contexts for gendered talk about depression (Emmons; 
Hurt).
11. A gulf often exists between the abstract possibility and the material conditions necessary to be able to 
actually exercise choice. This disparity has long been acknowledged when discourses of reproduc-
tive freedom bump up against discourses of reproductive justice. For example, the widespread avail-
ability and relative reliability of the birth control pill allows some women (those who have access to 
health care and can afford prescriptions) to seize control of their own reproductive futures, yet it has 
also enabled an unsavory history of medical experimentation, in which women of color, economically 
underprivileged women, and women with disabilities have been targets of forced population control 
(Smith 131–32). See also Price, Rapp, and Mitchell and Happe on the role of race, gender, and class 
and informed consent in genetics.
12. Menstrual pain can take a variety of forms but may include headaches, migraines, bloating, upset 
stomach, cramping, and pain and pressure in the abdomen, lower back, thighs, and hips. Although 
highly contested, PMS and PMDD are related women’s health conditions that can also result in phys-
ical, emotional, and psychological pain. Some argue that the treatment of PMS and PMDD is impor-
tant for women to live less painful lives, while others believe that PMS and PMDD are labels used to 
medicalize women’s bodies (Ussher 84). For example, Jane Ussher sees PMS as a rhetorical accom-
plishment that “is constructed through women’s narratives, and through the public and private dis-
course produced by experts” (39).
13. On this point, Susan J. Douglas’s concept of “enlightened sexism” is illuminating. She makes sense of 
the ideological generation gap by suggesting that media-driven images of women in power have cre-
ated false postfeminist fantasies that indicate that feminism’s work is done.
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14. This “unbranded educational campaign” provided links so that savvy consumers could trace each el-
ement of the campaign back to Bayer Healthcare Pharmaceuticals, providing a level of transparency 
that is not always apparent in viral marketing efforts.
15. Both wngti.com and UnderstandPMDD.com are currently offline. The original Web sites can be 
viewed on the Internet Archive’s Wayback Machine (http://www.archive.org).
16. The Loestrin campaign launched with an emphasis on shortening menstrual periods, with Cammie as 
the major figure in the online and television advertisements. Since 2008, the campaign has been up-
dated, excising Cammie and boasting a new slogan: “Short, light … right.”
17. Like Yaz, early Seasonale television advertisements received FDA warnings for minimizing safety 
risks associated with the drug (see Chitale).
18. However, the Website concedes one drawback upfront: “While you get the convenience of 4 periods a 
year, you are also more likely to have spotting and breakthrough bleeding (which varies from slight 
spotting to a flow much like a regular period) than with a traditional monthly birth control pill. This 
is common and should decrease over time. During the first year, total bleeding days are similar to a 
traditional birth control Pill” (Seasonale.com).
19. It is worth questioning whether parallel arguments are already in circulation for women who choose 
to embrace other identifiable links between women, such as the ability to bear children, or individuals 
who choose not to take hormonal birth control. For more on the institutional nonacceptance of men-
struation, see Young’s “Menstrual Meditations” in On Female Body Experience, pp. 113–17.
20. An instructive example is the Boston Women’s Health Book Collective’s Our Bodies, Ourselves, which 
treats menstrual suppression, like many scientific controversies, as an issue that is still open for de-
bate. The reason for this is twofold: lack of scientific information on the long-term impacts of men-
strual suppression and cultural reservations (e.g., “How can we make informed choices about men-
struation in a culture that tells us that we are dirty when we bleed?”; 255). Marianne MacPherson, the 
primary editor of the “Sexual Anatomy, Reproduction, and Menstruation” chapter in Our Bodies, Our-
selves notes that she chose not to discuss specific companies or products because it might “obscure the 
larger debate around the safety and desirability of menstrual suppression in general” (194).
21. There are a number of texts—some fantastical, some not—that explicitly value menstruation, includ-
ing Dena Taylor’s Red Flower; Gloria Steinem’s “If Men Could Menstruate” in her Outrageous Acts and 
Everyday Rebellions); and Gerd Brantenberg’s Egalia’s Daughters, which includes the Grand Menstrua-
tion Games (249–55).
22. This is akin to what Catriona Mackenzie and Natalie Stoljar call “relational autonomy” or the “impli-
cations of the intersubjective and social dimensions of selfhood and identity for conceptions of indi-
vidual autonomy and moral and political agency” (4).
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